Island Pharmaceuticals Limited (7X0)

Overview

Island Pharmaceuticals Limited is a drug research and repurposing company that primarily focuses on the innovation and development of preventative and therapeutic drugs targeting viral infections. With its base in Camberwell, Australia, and active operations in both Australia and the United States, the company seeks to address significant health challenges posed by viral pathogens. Founded in 2017, Island Pharmaceuticals is committed to advancing treatments for diseases transmitted by mosquitoes, notably dengue fever, through its lead product candidate, ISLA-101. The company collaborates with reputable institutions, including Monash University and the National Cancer Institute IND, highlighting its solid foundation in scientific research and development. Additionally, Island Pharmaceuticals has entered into a cooperative research and development agreement with the U.S. Army, paving the way for its crucial Phase 2a/b clinical studies for its leading drug candidate.

Products and Services

• ISLA-101

  ISLA-101 is Island Pharmaceuticals' leading product candidate designed for the prevention and treatment of dengue fever, as well as other diseases transmitted by mosquitoes. The drug aims to reduce the incidence and severity of these viral infections, ultimately improving health outcomes for affected populations. With its current Phase 2a/b clinical study, ISLA-101 is at a pivotal stage of development, having already received support through collaborative research efforts.

• Research and Development Collaboration

  Island Pharmaceuticals engages in collaborative research and development to enhance its product pipeline and leverage scientific expertise. The company has established significant partnerships, including agreements with Monash University and the U.S. Army. These collaborations not only provide access to advanced research capabilities but also facilitate the clinical development and testing of its products.

• Drug Repurposing

  In addition to developing novel drugs, Island Pharmaceuticals specializes in drug repurposing, which involves finding new therapeutic uses for existing medications. This strategic approach accelerates the drug development process and may yield effective treatment options for viral infections with lower developmental costs and risks, thereby benefiting healthcare systems and patients alike.